• 1. Synthesis of an amphiphilic hyperbranched polymer as a novel pH-sensitive drug carrier
  Rui Chen,Liqun Wang RSC Adv. 2015 5 20155
• 2. pH-responsive flower-like micelles constructed via oxime linkage for anticancer drug delivery
  Bing Liu,Hongying Chen,Xiao Li,Chaonan Zhao,Yakun Liu,Lijuan Zhu,Hongping Deng,Jichen Li,Guolin Li,Fulin Guo,Xinyuan Zhu RSC Adv. 2014 4 48943
• 3. Prompt site-selective DNA hydrolysis by Ce(iv)–EDTA using oligonucleotide multiphosphonate conjugates
  Tuomas L?nnberg,Yuta Suzuki,Makoto Komiyama Org. Biomol. Chem. 2008 6 3580
• 4. Synthesis of novel cyanine–fullerene dyads for photovoltaic devices
  Fanshun Meng,Jianli Hua,Kongchang Chen,He Tian,Libero Zuppiroli,Frank Nüesch J. Mater. Chem. 2005 15 979
• 5. Chiral poly(l-lactic acid) driven helical self-assembly of oligo(p-phenylenevinylene)
  S. Kumari Nisha,S. K. Asha J. Mater. Chem. C 2014 2 2051

• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Application of 4-(2-Hydroxyethoxy)benzaldehyde (CAS: 22042-73-5) in Chemical Biology and Pharmaceutical Research

4-(2-Hydroxyethoxy)benzaldehyde (CAS: 22042-73-5) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its hydroxyethoxy and benzaldehyde functional groups, serves as a key building block in the synthesis of various bioactive molecules. Recent studies have explored its utility in drug discovery, material science, and bioconjugation strategies, highlighting its broad applicability in the field.

One of the most notable advancements involves the use of 4-(2-Hydroxyethoxy)benzaldehyde in the development of novel prodrugs and drug delivery systems. Researchers have leveraged its reactive aldehyde group to create Schiff base linkages with amine-containing drugs, enabling controlled release mechanisms. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the successful conjugation of this compound with anticancer agents, resulting in enhanced solubility and targeted delivery to tumor tissues. The study reported a significant reduction in systemic toxicity while maintaining therapeutic efficacy.

In addition to its role in drug delivery, 4-(2-Hydroxyethoxy)benzaldehyde has been employed in the synthesis of fluorescent probes for bioimaging applications. A recent publication in Chemical Communications detailed the development of a near-infrared fluorescent probe derived from this compound, which exhibited high selectivity for reactive oxygen species (ROS) in cellular environments. This innovation provides a valuable tool for real-time monitoring of oxidative stress in pathological conditions, such as cancer and neurodegenerative diseases.

Furthermore, the compound's unique chemical properties have been exploited in material science, particularly in the design of polymer-based biomaterials. A 2024 study in Biomaterials Science showcased the incorporation of 4-(2-Hydroxyethoxy)benzaldehyde into hydrogels, resulting in materials with tunable mechanical properties and biocompatibility. These hydrogels demonstrated potential for use in tissue engineering and wound healing applications, owing to their ability to support cell adhesion and proliferation.

Despite these promising developments, challenges remain in optimizing the synthesis and scalability of 4-(2-Hydroxyethoxy)benzaldehyde-derived compounds. Recent efforts have focused on green chemistry approaches to improve yield and reduce environmental impact. For example, a 2023 study in Green Chemistry reported a solvent-free catalytic method for the synthesis of this compound, achieving high purity and efficiency while minimizing waste generation.

In conclusion, 4-(2-Hydroxyethoxy)benzaldehyde (CAS: 22042-73-5) continues to be a valuable asset in chemical biology and pharmaceutical research. Its multifunctional nature enables diverse applications, from drug delivery to bioimaging and biomaterials. Ongoing research aims to further explore its potential and address existing limitations, paving the way for innovative therapeutic and diagnostic tools. Future studies should focus on translational applications to bridge the gap between laboratory findings and clinical implementation.

• 825620-40-4(Benzaldehyde, 4-(3,6,9,12,15-pentaoxahexadec-1-yloxy)-)
• 103660-61-3(4-(2-phenoxyethoxy)benzaldehyde)
• 60345-97-3(3-(2-Hydroxyethoxy)benzaldehyde)
• 64994-51-0(4-2-(2-methoxyethoxy)ethoxybenzaldehyde)
• 34074-28-7(Benzaldehyde,4,4'-[1,2-ethanediylbis(oxy)]bis-)
• 153364-63-7(m-PEG4-benzaldehyde)
• 111550-46-0(Benzaldehyde,4,4'-[oxybis(2,1-ethanediyloxy)]bis-)
• 111550-48-2(Benzaldehyde,4,4'-[1,2-ethanediylbis(oxy-2,1-ethanediyloxy)]bis-)
• 197513-69-2(Benzaldehyde, 4-(3,6,9,12-tetraoxatridec-1-yloxy)-)
• 36824-00-7(4-(2-methoxyethoxy)benzaldehyde)